The genetics of Parkinson's disease: unlocking personalised treatments

Why are some individuals vulnerable to Parkinson's disease? The prevalence of Parkinson's disease is the fastest growing among neurodegenerative disorders. Due to longer life expectancies and a higher proportion of elderly people, prevalence of the disease will continue to rise unless prevention strategies are found. The discovery of genetic variants that can lead to this movement disorder has revolutionised our understanding of the mechanisms that must be tackled to stop or delay neurodegeneration. Hear from Professor Thomas Gasser, a pioneer in the research of the genetic factors underlying Parkinson's disease, as he presents an overview of over two decades of advances in Parkinson's disease genetics. This presentation is followed by a lively panel discussion with Tanya Simuni, Professor of Neurology at Northwestern University Feinberg School of Medicine (USA), and Christine Klein, Professor of Neurology and Neurogenetics at University of Lübeck (Germany), who reflect on how these genetic discoveries have influenced their clinical practice and can contribute to new diagnostic criteria. The webinar is chaired by Elena Becker-Barroso, Editor-in-Chief of The Lancet Neurology, and includes a foreword from Kumsal Bayazit, CEO of Elsevier.